Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic

IMPORTANCE: Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. OBJECTIVE: To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespr...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Shuchi, Montez-Rath, Maria, Han, Jialin, Cadden, LinaCel, Hunsader, Patti, Kerschmann, Russell, Beyer, Paul, Boyd, Scott D., Garcia, Pablo, Dittrich, Mary, Block, Geoffrey A., Parsonnet, Julie, Chertow, Glenn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276082/
https://www.ncbi.nlm.nih.gov/pubmed/34251441
http://dx.doi.org/10.1001/jamanetworkopen.2021.16572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276082/
https://www.ncbi.nlm.nih.gov/pubmed/34251441
http://dx.doi.org/10.1001/jamanetworkopen.2021.16572

Ejemplares similares